查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468150

2024-2032 年单株抗体市场报告（依生产方法、来源、适应症、最终用途和地区）

Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球IMARC Group抗体市场规模达到2,217亿美元。

单株抗体 (mAb) 是实验室生产的蛋白质，用作替代抗体，可增强、修改、恢復和模拟免疫系统对不必要的细胞的攻击。它们用于透过增强免疫系统来检测和靶向癌细胞以进行破坏。它们也用于阻断癌细胞与促进细胞生长的蛋白质之间的关联。此外，它们还可以阻止蛋白质的形成，使免疫系统细胞能够有效地对抗癌细胞。除此之外，单株抗体将放射治疗直接输送到癌细胞，并最大限度地减少放射对健康细胞的影响

单株抗体市场趋势：

目前，癌症、心臟病、中风、糖尿病和关节炎等慢性病的盛行率不断上升，是推动市场的关键因素之一。除此之外，领先的製造商也广泛投资于研发(R&D) 活动，推出用于治疗神经退化性疾病（如阿兹海默症、亨廷顿氏症、帕金森氏症和路易氏体病）的增强型单克隆抗体药物。他们也专注于各种行销策略来扩大客户群，这有助于市场的成长。此外，对治疗癌细胞、免疫抑制和免疫调节分子等各种抗原的人源化单株抗体的需求不断增长，为行业投资者提供了利润丰厚的成长机会。除此之外，全球对用于治疗癌症的具有成本效益的生物相似药的需求不断增加。这与蓬勃发展的医疗保健行业一起推动了市场的成长。此外，下一代定序等各种基因平台的技术进步正在提供积极的市场前景。此外，世界各地单株抗体生产中先进基因工程技术的应用增加。再加上大众对单株抗体疗法益处的认识不断提高，正在推动市场成长。

本报告回答的关键问题

  • 2023年全球单株抗体市场规模有多大？
  • 2024-2032年全球单株抗体市场的预期成长率是多少？
  • 推动全球单株抗体市场的关键因素是什么？
  • COVID-19对全球单株抗体市场有何影响？
  • 根据生产方法，全球单株抗体市场的细分情况如何？
  • 全球单株抗体市场依来源划分是怎样的？
  • 根据适应症，全球单株抗体市场的细分情况如何？
  • 根据最终用途，全球单株抗体市场的细分情况如何？
  • 全球单株抗体市场的重点区域有哪些？
  • 全球单株抗体市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球单株抗体市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依生产方法

  • 体内
    • 市场走向
    • 市场预测
  • 体外
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依来源

  • 鼠类
    • 市场走向
    • 市场预测
  • 嵌合体
    • 市场走向
    • 市场预测
  • 人性化
    • 市场走向
    • 市场预测
  • 人类
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依迹象

  • 癌症
    • 市场走向
    • 市场预测
  • 自体免疫疾病
    • 市场走向
    • 市场预测
  • 发炎性疾病
    • 市场走向
    • 市场预测
  • 传染性疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：最终用途别

  • 医院
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amgen Inc.
    • Biogen Inc.
    • F. Hoffmann-La Roche AG
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A6278

The global monoclonal antibodies market size reached US$ 221.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 392.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targetting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells

Monoclonal Antibodies Market Trends:

At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer's, Huntington's, Parkinson's, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global monoclonal antibodies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on production method, source, indication and end use.

Breakup by Production Method:

In Vivo

In Vitro

Breakup by Source:

Murine

Chimeric

Humanized

Human

Breakup by Indication:

Cancer

Autoimmune Diseases

Inflammatory Diseases

Infectious Diseases

Others

Breakup by End Use:

Hospitals

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global monoclonal antibodies market in 2023?
  • 2. What is the expected growth rate of the global monoclonal antibodies market during 2024-2032?
  • 3. What are the key factors driving the global monoclonal antibodies market?
  • 4. What has been the impact of COVID-19 on the global monoclonal antibodies market?
  • 5. What is the breakup of the global monoclonal antibodies market based on the production method?
  • 6. What is the breakup of the global monoclonal antibodies market based on the source?
  • 7. What is the breakup of the global monoclonal antibodies market based on the indication?
  • 8. What is the breakup of the global monoclonal antibodies market based on the end use?
  • 9. What are the key regions in the global monoclonal antibodies market?
  • 10. Who are the key players/companies in the global monoclonal antibodies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Monoclonal Antibodies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Production Method

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Murine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chimeric
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Humanized
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Human
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Inflammatory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Infectious Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Biogen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 GSK plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novo Nordisk A/S
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
  • Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2023
  • Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2023
  • Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2023
  • Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2023
  • Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
  • Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
  • Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million US$), 2024-2032
  • Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million US$), 2024-2032
  • Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
  • Table 8: Global: Monoclonal Antibodies Market: Key Players